BioPharm America EBD Group Massachusetts Biotechnology Council BioPharm America
Share:
Email this page Share this on LinkedIn Share this on Twitter

BioPharm America™ 2014 Press Releases

August 19, 2014Renewed investor appetite in biotech innovation means strong attendance expected at BioPharm America™ 2014 The seventh annual BioPharm America international life science partnering conference will be held September 22–24 at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event is a big draw for pharma and investors who want to access innovative new potential therapies and cures brought by international biotech companies. "Today is a great time...  more ►

May 20, 2014Collaborative models and IPO window are hot topics at BioPharm America™ 2014 program The seventh annual BioPharm America international life science partnering conference will be held September 22–24 at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event brings together industry thought leaders and high level executives in the biopharma dealmaking arena to collaborate on and discuss relevant trends and topics. Several i...  more ►

April 15, 2014BioPharm America™ 2014 returns to Boston's Copley Place and a celebration of the FierceBiotech Fierce 15 The seventh annual BioPharm America international life science partnering conference will be held at Boston Marriott Copley Place in the center of Boston's historic Back Bay. Produced by EBD Group in collaboration with the Massachusetts Biotechnology Council (MassBio), the September 22–24 event will bring the global life science industry to Boston to facilitate strategic ...  more ►



partnering360:Insight Latest headlines from partnering360:Insight

August 13, 2014 Gene, stem cell therapies bring new players to partnering The next generation of therapies built upon the science of stem cells and genetics will require new types of partnerships. If there is promise that these technologies can redefine how we understand and treat disease, there is already a certainty that the alliances and partnerships required to bring these therapies to patients are also beyond traditional models for commercialization. more ►

August 1, 2014 J&J: “Innovation delivers growth and growth sustains our innovation” "What we are really trying to accomplish is building more than a financial relationship. We are interested in truly finding a way to get to the outcomes. We want to keep our partners intimately involved in a pursuit of truth, in understanding what this science means in the lives of patients who might benefit the most from it. It is this dialogue we are after." more ►

July 28, 2014 Deal trends in Regenerative Medicine The field of regenerative medicine is an up-and-coming new approach for targeting and treating diseases, involving the repair and restoration of previously damaged tissues or organs in the body. According to the Current Agreements life science deals and alliance database, there have been over 700 regenerative medicine/stem cell deals in the last five years alone. more ►

July 22, 2014 Promethera expands portfolio with progenitor cell platform Eric Halioua arrives at BioPharm America™ in Boston this September carrying an expanding portfolio of partnering opportunities based on a platform of human liver progenitor cells. more ►

July 22, 2014 CoStim Pharma: People plus hot science create stunning combo-combo deal Pathways and platforms are great but true exits come around product portfolios, says Robert Millman, a founder and the chief executive for CoStim Pharmaceuticals, which was snapped up by Novartis just 10 months after the company's first funding round. more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD Group, Inc.
Privacy Policy
Terms of Use
BioPharm America EBD Group Massachusetts Biotechnology Council BioPharm America